4-Hexylresorcinol

Source: Wikipedia, the free encyclopedia.
(Redirected from
Hexylresorcinol
)
4-Hexylresorcinol
Clinical data
Trade namesS.T.37, Crystoids
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • 4-hexylbenzene-1,3-diol
JSmol)
Melting point68 to 69 °C (154 to 156 °F)
Boiling point333 to 335 °C (631 to 635 °F)
  • Oc1cc(O)ccc1CCCCCC
  • InChI=1S/C12H18O2/c1-2-3-4-5-6-10-7-8-11(13)9-12(10)14/h7-9,13-14H,2-6H2,1H3 checkY
  • Key:WFJIVOKAWHGMBH-UHFFFAOYSA-N checkY
  (verify)

4-Hexylresorcinol is an

local anaesthetic, antiseptic, and anthelmintic properties.[1]

As an antiseptic, it is marketed as S.T.37 by Numark Laboratories, Inc. (in a 0.1% solution) for oral pain relief and as a topical antiseptic. It is available for use topically on small skin infections or as an ingredient in throat lozenges.

As an anthelmintic, 4-hexylresorcinol was sold under the brand Crystoids.[citation needed] Sytheon Ltd., USA markets 4-hexylresorcinol (trade named Synovea HR).

anti-aging cream. 4-Hexylresorcinol has been used commercially by many cosmetic and personal care companies, such as Mary Kay, Clarins, Unilever, Murad, Facetheory, Arbonne
, and many small and large companies.

A study published in

Applied Sciences [3] shows that 4-hexylresorcinol did not change the expression of estrogen receptor-α, -β, or p-ERK1/2 in MCF-7 cells. In an ovariectomized animal model, the 4HR group showed similar levels of ERα, ERβ, and prolactin expression in the pituitary gland compared to the solvent only group, while the estradiol group showed higher levels. Serum prolactin levels were similar between the 4HR and solvent only groups.[3]

In one study, 4-hexylresorcinol increased the shelf life of shrimp by reducing melanosis (black spots).[4]

In mice with cancer, 4-hexylresorcinol inhibited NF-κB and extended their survival rate.[5]

4-Hexylresorcinol can be used in the synthesis of tetrahydrocannabihexol[6]

References

  1. ^ Gisvold O (1966). Wilson CO, Gisvold O, Doerge RF (eds.). Textbook of Organic Medicinal and Pharmaceutical Chemistry (5th ed.). Philadelphia: Lippincott. pp. 237–262.
  2. PMID 19063592
    .
  3. ^ .
  4. .
  5. .
  6. .